How to Help Your Patients Save Money on Onyda XR: A Provider's Guide to Savings Programs

As the first liquid non-stimulant ADHD medication, Onyda XR fills a genuine clinical gap — but its brand-name-only status means cost can be a significant barrier for families. Without insurance coverage, the retail price of Onyda XR is approximately $525 for a 30-day supply, which is prohibitive for many patients.

This guide gives you the clinical and practical information needed to help patients access Onyda XR at a manageable cost — including manufacturer savings programs, prior authorization strategies, and alternatives if cost remains a barrier.

Understanding Onyda XR Pricing

As a newly approved brand-name medication with no generic equivalent, Onyda XR is priced as a premium product:

Average retail price: ~$525 per 30-day supply (30 mL at standard doses)

GoodRx price: ~$398 with coupon at participating pharmacies

Insurance (commercial, Tier 3–4): $30–$100 copay depending on plan; prior authorization often required

Tris Savings Card: As low as $25/month for eligible patients

Tris Savings Card: The Most Impactful Intervention

The Tris Pharma savings card program is typically the most effective cost-reduction tool for commercially insured patients. Here are the details your practice needs:

Program name: Tris Savings Card

Website: TrisSavingsCard.com

Phone: 1-872-351-5682

Patient cost: As little as $25/month

Eligible patients: Commercially insured (covered or non-covered) and uninsured patients with commercial insurance eligibility

Ineligible: Medicare, Medicaid, TriCare, CHIP, Indian Health Service, and state pharmaceutical assistance programs

Also covers: Quillivant XR, QuilliChew ER, and Dyanavel XR — one card for all Tris ADHD products

Proactive Prior Authorization: Prevent Coverage Denials at the Pharmacy

Many commercial plans require prior authorization (PA) for Onyda XR because it is a newer brand-name drug that may require step therapy documentation. The most effective approach is to initiate the PA at the time of prescribing — before the patient attempts to fill.

Key elements of a strong PA for Onyda XR:

ADHD diagnosis: DSM-5 criteria with documentation of severity and functional impairment

Medical necessity for liquid formulation: Document inability to swallow tablets if relevant (dysphagia, developmental factors)

Step therapy evidence: If required, document prior treatment attempts, responses, and reasons for discontinuation

Reason non-stimulant is preferred: Stimulant intolerance, comorbid anxiety, tic disorders, cardiac contraindications, or family preference with clinical rationale

Managing Medicaid and CHIP Patients

Medicaid and CHIP coverage for Onyda XR varies significantly by state. Some state Medicaid programs cover newer brand-name ADHD medications; others require extensive step therapy. For Medicaid patients who can't access Onyda XR through their insurance:

Consider generic clonidine ER tablets (Kapvay generic) — same active ingredient at significantly lower cost, though dose adjustment is required when switching from Onyda XR

Consider generic guanfacine XR (Intuniv generic) — same drug class, once-daily, typically covered by most Medicaid programs

Contact Tris Pharma at 1-732-940-0358 to inquire about patient assistance program availability for uninsured patients

GoodRx and Third-Party Discount Cards

For patients who are not eligible for the Tris Savings Card (or for whom the card doesn't offer a sufficient discount), GoodRx and SingleCare coupons can reduce the retail price of Onyda XR to approximately $398. Note that patients cannot combine GoodRx and the Tris Savings Card at the same fill — advise them to compare both options and choose the lower cost.

90-Day Mail Order: Reducing Per-Fill Cost

Since Onyda XR is not a controlled substance, you can prescribe 90-day supplies. Mail-order pharmacies through PBMs (Express Scripts, OptumRx, CVS Caremark) often offer lower per-dose costs and more consistent availability than retail. For commercially insured patients, a 90-day mail-order supply typically costs 2x the 30-day copay rather than 3x, saving patients one month's worth of cost.

Cost-Effectiveness Conversation With Families

When introducing Onyda XR to a family, address cost proactively. A simple statement like: "This is a brand-new medication, so the retail price is higher. But with the manufacturer's savings card, most commercially insured families pay around $25 a month. Let's check your insurance and get you enrolled before you leave today" sets appropriate expectations and reduces abandonment at the pharmacy.

For help locating Onyda XR for your patients, medfinder for providers calls pharmacies near your patient to check which ones can fill the prescription — reducing patient frustration and prescription abandonment.

For guidance on finding Onyda XR stock for patients, see: How to Help Your Patients Find Onyda XR in Stock: A Provider's Guide.